Arthritis Completed Phase 2 Trials for Ulodesine (DB12353)

Also known as: Articular inflammation / Unspecified osteoarthritis, unspecified site / Inflammatory arthritis / Arthritis (disorder) / Arthritis NOS

IndicationStatusPhase
DBCOND0016433 (Arthritis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01407874A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal InsufficiencyTreatment
NCT01265264Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral Ulodesine Added to AllopurinolTreatment